LZTS2 anticorps
-
- Antigène Voir toutes LZTS2 Anticorps
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp LZTS2 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Purification
- Immunogen affinity purified
- Pureté
- ≥95 % as determined by SDS-PAGE
- Immunogène
- leucine zipper, putative tumor suppressor 2
- Isotype
- IgG
- Top Product
- Discover our top product LZTS2 Anticorps primaire
-
-
- Indications d'application
- WB: 1:500-1:2000, IHC: 1:20-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Date de péremption
- 12 months
-
- Antigène
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
- Autre désignation
- LZTS2 (LZTS2 Produits)
- Sujet
- Synonyms:KIAA1813, LAPSER1 Background:Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin.
- Poids moléculaire
- 70-80 kDa
- ID gène
- 84445
- UniProt
- Q9BRK4
-